Vascular imaging market will near $6 billion by 2022

By Romily Broad
New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95bill...

New research suggests that the global market for vascular imaging technlogies will accelerate 6.5% per year over the next five years, up to USD$5.95 billion by 2022.

The research from MarketsAndMarkets identifies the primary drivers as improving technlogies, aging populations, and the increasing prevelance of cardiovascular diseases (CVDs). It says North America will represent the largest market share geographically, featuring as it does both an aging population susceptible to high rates of CVD and the greatest dispursment of investment in new technlogies.

Of the technologies driving most growth, magnetic resonance imaging will dominate the market in 2017, continuing to be the preferred choice due to its non-invasiveness and high efficacy. 

Coronary angiography will dominate the cardiovascular procedure segment of the market, primarily driven by the ever increasing geriatric population of the world.

The projection sees a overall value uplift of over 25% on a market worth $4.35 billion today.

Share

Featured Articles

Vaccine Breakthrough on Antibiotics Resistant Diseases

As researchers report breakthrough on vaccine against MRSA bacteria, we look at which pharmas are working on vaccines to combat antimicrobial resistance

Oracle Fusion Cloud Update Boost for Patients

Oracle Fusion Cloud SCM includes new Healthcare Marketplace solution to help hospitals & clinics optimise planning, automate processes and improve outcomes

WHO Tightens air Quality Guidelines as Pollution Kills 7mn

World Health Organisation tightens air pollution guidelines to safeguard health; COVID prompts WHO to redefine 'air-borne' as it relates to diseases

WHO Health Chatbot Built on 'Humanised' GenAI

Digital Healthcare

Costco Weight-Loss Drugs Move Highlights US AOM Growth

Medical Devices & Pharma

AstraZeneca Company Profile, as CEO Soriot Lands pay Deal

Medical Devices & Pharma